| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10916094 | Nuclear Medicine and Biology | 2012 | 6 Pages |
Abstract
Our data demonstrate that difference exists between CHO PET and MRI by which to judge and identify residual tumor for patients with brain gliomas. CHO PET is considered to be a supplementary diagnostic approach for MRI. Biological tumor target volume (BTV) displayed in the CHO PET images is useful in determining or delineating the radiotherapy target volume and making decisions in selecting treatment regimens. Tumor target volume may be defined more accurately and rationally when the CHO PET is combined with MRI.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Fang-Ming Li, Qing Nie, Rui-Min Wang, Susan M. Chang, Wen-Rui Zhao, Qi Zhu, Ying-Kui Liang, Ping Yang, Jun Zhang, Hai-Wei Jia, Heng-Hu Fang,